Dianthus Therapeutics, Inc. Common Stock (NASDAQ: DNTH) last traded at $111.10, up 1.45% on the session. The quote above updates while this page is open; the figures below are drawn from Dianthus Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Dianthus Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker DNTH. Its market capitalisation is $6.21 billion.
Valuation measures for Dianthus Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $6.21B |
|---|---|
| Enterprise value | $6.15B |
| Price / sales | 3052.21 |
| Price / book | 5.30 |
| Beta | 0.92 |
Trailing-twelve-month figures tagged in Dianthus Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $2.04M |
|---|---|
| Net income (TTM) | -$192.25M |
| EPS (TTM) | -$4.25 |
| Operating margin | -10699.61% |
| Return on equity | -16.40% |
| Cash | $110.55M |
Range and volume for DNTH over the past 52 weeks.
| 52-week high | $117.88 |
|---|---|
| 52-week low | $22.81 |
| Volume | 713.2K |
| Average volume | 1.06M |
| Previous close | $109.51 |
Dividend history for Dianthus Therapeutics, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.